Stimcell Energetics (STME) Cash & Equivalents Growth (3y) (2014 - 2026)
Stimcell Energetics (STME) Cash & Equivalents Growth (3y) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.81 Bn | 193.21 Bn | 7.27 Bn | -13.31% |
| 2 | Stryker | 127.76 Bn | 124.28 Bn | 4.50 Bn | 34.27% |
| 3 | Medtronic | 118.77 Bn | 109.55 Bn | 6.41 Bn | 8.10% |
| 4 | Boston Scientific | 73.25 Bn | 72.71 Bn | 3.85 Bn | 8.16% |
| 5 | Edwards Lifesciences | 51.93 Bn | 47.68 Bn | 1.35 Bn | 40.74% |
| 6 | Dexcom | 34.43 Bn | 32.49 Bn | 830.00 Mn | -2.57% |
| 7 | GE HealthCare Technologies | 33.88 Bn | 31.77 Bn | 2.18 Bn | 2.72% |
| 8 | Koninklijke Philips | 26.35 Bn | 23.03 Bn | 4.55 Bn | 38.28% |
| 9 | Steris | 23.11 Bn | 22.63 Bn | 684.20 Mn | 32.23% |
| 10 | Stimcell Energetics | 4.65 Mn | 4.64 Mn | - | 10.37% |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | 10.37% |
| Nov 30, 2025 | 37.35% |
| Aug 31, 2025 | -12.53% |
| May 31, 2025 | -15.75% |
| Feb 28, 2025 | -39.88% |
| Nov 30, 2024 | -3.08% |
| Aug 31, 2024 | -31.44% |
| May 31, 2024 | 27.89% |
| Feb 29, 2024 | 45.31% |
| Nov 30, 2023 | 1.27% |
| Aug 31, 2023 | -21.59% |
| May 31, 2023 | 29.66% |
| Feb 28, 2023 | -59.29% |
| Nov 30, 2022 | -59.84% |
| Aug 31, 2022 | -69.90% |
| May 31, 2022 | -24.73% |
| Feb 28, 2022 | -38.30% |
| Nov 30, 2021 | 15.08% |
| Aug 31, 2021 | 67.04% |
| May 31, 2021 | 36.28% |